Cited by 592Helicobacter pylori-related gastroenterology studiesCardiovascular Health and Risk FactorsAtherosclerosis and Cardiovascular Diseases

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors

Open access

Patel, P, Mendall, M A, Carrington, D, Strachan, D P, Leatham, E, Molineaux, N, Levy, J, Blakeston, C, Seymour, C A, Camm, A J, Northfield, T C·1995·BMJ

DOI 10.1136/bmj.311.7007.711PMC PMC2550716

Open this paper in CoChat — free account

Abstract

Objective: To investigate the relation between seropositivity to chronic infections with Helicobacter pylori and Chlamydia pneumoniae and both coronary heart disease and cardiovascular risk factors. Objective:To investigate the relation between seropositivity to chronic infections with Helicobacter pylori and Chlamydia pneumoniae and both coronary heart disease and cardiovascular risk factors. Setting: General practices in Merton, Sutton, and Wandsworth, south London. Subjects: 388 white south London men aged 50-69. Main outcome measures: Evidence of coronary risk factors and infection with H pylori or C pneumoniae. Results: 47 men (12.1%) had electrocardiographic evidence of ischaemia or infarction. 36 (76.6%) and 18 (38.3%) were seropositive for H pylori and C pneumoniae, respectively, compared with 155 (45.5%) and 62 (18.2%) men with normal electrocardiograms. Odds ratios for abnormal electrocardiograms were 3.82 (95% confidence interval 1.60 to 9.10) and 3.06 (12.33 to 7.01) in men seropositive for H pylori and C pneumoniae, respectively, after adjustment for a range of socioeconomic indicators and risk factors for coronary heart disease. Cardiovascular risk factors that were independently associated with seropositivity to H pylori included fibrinogen concentration and total leucocyte count. Seropositivity to C pneumoniae was independently associated with raised fibrinogen and malondialdehyde concentrations. Conclusions: Both H pylori and C pneumoniae infections are associated with coronary heart disease. These relations are not explained by a wide range of confounding factors. Possible mechanisms include an increase in risk factor levels due to a low grade chronic inflammatory response.

Integrity signals

Registry

Crossref · 10.1136/bmj.311.7007.711

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens
Clauss, A. (2009) · Acta Haematologica · doi:10.1159/000205234 · Cited by 3,239
Cardiovascular Survey Methods.
Rose, G., & Blackburn, H. (1968) · Annals of Internal Medicine · doi:10.7326/0003-4819-69-6-1335_2 · Cited by 3,090
SEROLOGICAL EVIDENCE OF AN ASSOCIATION OF A NOVEL CHLAMYDIA, TWAR, WITH CHRONIC CORONARY HEART DISEASE AND ACUTE MYOCARDIAL INFARCTION
Saikku, P., Mattila, K. J., Nieminen, M. S., Huttunen, J. K., Leinonen, M., Ekman, M.-R., Mäkelä, P. H., & Valtonen, V. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90741-6 · Cited by 1,961
HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDY
Meade, T. W., Brozović, M., Chakrabarti, R., Haines, A., Imeson, J., Mellows, S., Miller, G. J., North, W. R. S., Stirling, Y., & Thompson, S. G. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90111-x · Cited by 1,937
The diagnosis of ischaemic heart pain and intermittent claudication in field surveys.
Rose, G. A. (1962) · Europe PMC (PubMed Central) · Cited by 1,328
Association between dental health and acute myocardial infarction.
Mattila, K. J., Nieminen, M. S., Valtonen, V., Rasi, V., Kesäniemi, Y. A., Syrjala, S. L., Jungell, P., Isoluoma, M., Hietaniemi, K. L., & Jokinen, M. J. (1989) · BMJ · doi:10.1136/bmj.298.6676.779 · Cited by 1,057
Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies.
YARNELL, J. W. G., Baker, I. A., Sweetnam, P. M., Bainton, D., O'Brien, J. R., WHITEHEAD, P. J., & Elwood, P. C. (1991) · Circulation · doi:10.1161/01.cir.83.3.836 · Cited by 915
Chronic Chlamydia pneumoniae Infection as a Risk Factor for Coronary Heart Disease in the Helsinki Heart Study
Saikku, P., Leinonen, M., Tenkanen, L., Linnanmäki, E., Ekman, M.-R., Manninen, V., Mänttäri, M., Frick, M. H., & Huttunen, J. K. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-4-273 · Cited by 785
Demonstration of Chlamydia pneumoniae in Atherosclerotic Lesions of Coronary Arteries
Kuo, C. C., Shor, A., Campbell, L. A., Fukushi, H., Patton, D. L., & Grayston, J. T. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/167.4.841 · Cited by 763
Relation of Helicobacter pylori infection and coronary heart disease.
Mendall, M. A., Goggin, P. M., Molineaux, N., Levy, J., Toosy, T., Strachan, D. P., Camm, A. J., & Northfield, T. C. (1994) · Heart · doi:10.1136/hrt.71.5.437 · Cited by 657
Self-citation

Show all 32 references

Research works printed but not linked: 3

Mendall, 1992, Helicobacter pylori screening prior to endoscopy., European Journal of Gastroenterology and Hepatology, 4, 713
Baker RJ Nelder JA .The GLIM system manual, release 3. Oxford: Numerical Algorithms Group,1978.
Darougar, 1983, Trachoma., Br Med Bull, 39, 117, 10.1093/oxfordjournals.bmb.a071801 · DOI

Sorted by citations

Items 401–500 of 590

Identification of Chlamydia pneumoniae in intracranial and extracranial arteries in patients with stroke and in controls: combined immunohistochemical and polymerase chain reaction analyses☆
Wohlschlaeger, J., Wimmer, M. L. J., Nägler, D. K., Haberl, R. L., & Weis, S. (2005) · Human Pathology · doi:10.1016/j.humpath.2005.02.003 · Cited by 11
Extent of Coronary Atherosclerosis and Homocysteine Affect Endothelial Markers
Yı́ldı́rı́r, A., Tokgozoglu, S. L., Haznedaroğlu, İ. C., Lay, İ., Kabakçı, G., Övünç, K., Aksöyek, S., Oto, A., Özmen, F., Kirazlı, Ş., et al. (2001) · Angiology · doi:10.1177/000331970105200902 · Cited by 11
Oral Microorganisms and Cardiovascular Disease
Pallasch, T. J., & Slots, J. (2000) · Journal of the California Dental Association · doi:10.1080/19424396.2000.12223070 · Cited by 10
Neopterin levels in patients with coronary artery disease are independent of chlamydia pneumoniae seropositivity
Smith, D. A., Zouridakis, E., Mariani, M., Fredericks, S., Cole, D., & Kaski, J. C. (2003) · American Heart Journal · doi:10.1016/s0002-8703(03)00101-7 · Cited by 10
A Look at Infectious Agents as a Possible Causative Factor in Cardiovascular Disease: Part I
Vojdani, A. (2003) · Laboratory Medicine · doi:10.1309/0428-w4ef-e7j6-yt40 · Cited by 10
Helicobacter pylori and the Future: An Afterword
Mann, N. S., & Westblom, T. U. (1999) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-60013-5_14 · Cited by 10
Role of Helicobacter pylori Infection in Pathogenesis, Evolution, and Complication of Atherosclerotic Plaque
Ciarambino, T., Crispino, P., Minervini, G., & Giordano, M. (2024) · Biomedicines · doi:10.3390/biomedicines12020400 · Cited by 9
Helicobacter pylori Gastritis, a Presequeale to Coronary Plaque
Raut, S. C., Patil, V. W., Dalvi, S. M., & Bakhshi, G. D. (2015) · Clinics and Practice · doi:10.4081/cp.2015.717 · Cited by 9
Role of C-Reactive protein and periodontal disease in systemic health: A review
Smitha, C. N., Soni, S., & Basu, S. K. (2011) · Journal of Advanced Oral Research · doi:10.1177/2229411220110101 · Cited by 9
Helicobacter pylori infection does not accelerate the age‐related progression of arteriosclerosis: A 4‐year follow‐up study
Honda, C., Adachi, K., Arima, N., Tanaka, S., Yagi, J., Morita, T., Tanimura, T., Furuta, K., & Kinoshita, Y. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05343.x · Cited by 9
The possible role of infections in acute myocardial infarction
Meier, C. R. (1999) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(99)80118-8 · Cited by 9
Chlamydophila pneumoniae antibodies may be independently associated with increased BMI and percentage of body fat among women
Jaworowska, A., & Bazylak, G. (2011) · International Journal of Obesity · doi:10.1038/ijo.2010.267 · Cited by 9
Helicobacter pylori Infection: Epidemiology and Occupational Risk for Health Care Workers
Schryver, A. D., & Winckel, M. V. (2001) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v30n5p457 · Cited by 9
Periodontitis as a risk factor in patients with ischemic heart disease.
Delgado, O. L., Echevarría-García, J. J., Berini‐Aytés, L., & Gay‐Escoda, C. (2004) · PubMed · Cited by 9
Chlamydia Pneumonia Seropositivity Correlates with Serum Fibrinogen and Lipoprotein a Levels: Any Role in Atherosclerosis?
Tütüncü, N. B., Guvener, N. D., Tütüncü, T., YILMAZ, M., Güvener, M., Böke, E., Paşaoğlu, İ., & Erbas, T. A. (2001) · Endocrine Journal · doi:10.1507/endocrj.48.269 · Cited by 9
Respiratory infection and coronary heart disease: progression of a paradigm
Grimes, D. S. (2000) · QJM · doi:10.1093/qjmed/93.6.375 · Cited by 9
Weighing the evidence for infection as a risk factor for coronary heart disease
O’Donnell, C. J., & Levy, D. A. (2000) · Current Cardiology Reports · doi:10.1007/s11886-000-0082-6 · Cited by 9
Chlamydia Pneumoniae and Coronary Heart Disease
Carlisle, S. S., & Nahata, M. C. (1999) · Annals of Pharmacotherapy · doi:10.1345/aph.18169 · Cited by 9
Chlamydia pneumoniae and atherosclerosis.
Wong, Y.-K., & Ward, M. E. (1999) · Journal of Clinical Pathology · doi:10.1136/jcp.52.5.398b · Cited by 9
Molecular study of human herpesvirus 6 and 8 involvement in coronary atherosclerosis and coronary instability
Magnoni, M., Malnati, M., Cristell, N. A., Coli, S., Russo, D., Ruotolo, G., Cianflone, D., Alfieri, O., Lusso, P., & Maseri, A. (2012) · Journal of Medical Virology · doi:10.1002/jmv.23355 · Cited by 8
The effect of garlic consumption on Helicobacter pylori treatment using urea breath test: a randomized clinical trial
Hekmatdoost, A., Ghobeh, M., Shakerhosseini, R., Mirsattari, D., Rastmanesh, R., Rashidkhani, B., & Navai, L. (2015) · Cited by 8
Novel IL-6-secreting γδT cells increased in patients with atherosclerotic cerebral infarction
He, Y., MA, N., Chen, X., WANG, X., Xiao, H., Zheng, M., Han, G., Chen, G., Hou, C., Shen, B., et al. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2796 · Cited by 8
Long-term trends in cardiovascular disease mortality and association with respiratory disease
MERCER, A. J. (2015) · Epidemiology and Infection · doi:10.1017/s0950268815001818 · Cited by 8
Prognostic value of infection and inflammation markers for late cardiac events in an Iranian sample.
Sarrafzadegan, N., Rezaporian, P., Kaypour, M., Mohseni, M., Sadeghi, M., Asgary, S., & Sabet, B. (2008) · PubMed · Cited by 8
Study of arteriosclerosis in patients with hiatal hernia and reflux esophagitis
Furuta, K., Adachi, K., Arima, N., Yagi, J., Tanaka, S., Miyaoka, Y., Miki, M., Azumi, T., Koshino, K., Ishihara, S., et al. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04360.x · Cited by 8
Immune Responses to Chlamydia Antigens in Atherosclerosis
Gaston, H., Curry, A. J., Portig, I., GOODALL, J. C., & Kirkpatrick, P. J. (2000) · Herz · doi:10.1007/pl00001954 · Cited by 8
Chlamydia pneumoniae IgG and the severity of coronary atherosclerosis
Järemo, P., & Richter, A. (2004) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2004.07.011 · Cited by 8
Infection, immunisation and atherosclerosis: is there a link?
Lamb, D. J., & Ferns, G. A. (1999) · Vaccine · doi:10.1016/s0264-410x(98)00234-5 · Cited by 8
Risk Factors for Coronary Heart Disease and Persistent Infection withChlamydia Pneumoniaeor Cytomegalovirus: A Population-Based Study
Danesh, J., Wong, Y.-K., Ward, M. E., & Muir, J. (1999) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/204748739900600605 · Cited by 8
Antibodies to Chlamydia pneumoniae and clinical course in patients with unstable angina pectoris
de Maat, M. P. M., Ossewaarde, J. M., Verheggen, P. W. H. M., Kluft, C., Cats, V. M., & Haverkate, F. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(00)00436-6 · Cited by 8
Changes in coagulation-fibrinolysis balance in blood mononuclear cells and in gastric mucosa from patients with Helicobacter pylori infection
Colucci, M., Rossiello, M. R., Pentimone, A., Berloco, P. B., Russo, F., Leo, A. D., & Semeraro, N. (2005) · Thrombosis Research · doi:10.1016/j.thromres.2005.02.008 · Cited by 7
Chlamydia Pneumoniae and Helicobacter Pylori Serology - Importance in Patients with Coronary Heart Disease
Grdanoska, T., Zafirovska, P., Jaglikovski, B., Pavlovska, I., Zafirova, B., Trajkovska, K. T., Trajkovska-Dokic, E., Petrovska, M., Cekovska, Z., Kondova-Topuzovska, I., et al. (2012) · Materia Socio Medica · doi:10.5455/msm.2012.24.151-156 · Cited by 7
Relation of Cag-A-positive Helicobacter pylori strain and some inflammatory markers in patients with ischemic heart diseases.
El-Mashad, N., Elemshaty, W., Arfat, M. S., Koura, B. A., & Metwally, S. S. (2009) · PubMed · Cited by 7
Association between Helicobacter. pylori and coronary artery disease
Davoudi, S., Omran, A. S., Boroumand, M. A., Rahimian, N., & Saadat, S. (2010) · Open Medicine · doi:10.2478/s11536-010-0051-4 · Cited by 7
Helicobacter pylori Seropositivity and Atherosclerosis Risk Factors
Köksal, A. Ş., Ekmekçi, Y., Karadeniz, Y., Köklü, S., Apan, T. Z., Yilmaz, M., Sezikli, M., İnal, B., Demirel, T., & Yıldız, A. (2004) · Digestive Diseases · doi:10.1159/000083603 · Cited by 7
Association of Helicobacter pylori and Coronary heart disease in Iran: A meta-analysis
Rahmani, Y., Mohammadi, S., Karim, H., Rezazadeh, M., Babanejad, M., Shahmohammadi, A., & Rai, A. (2018) · Medical Journal of the Islamic Republic of Iran · doi:10.14196/mjiri.32.73 · Cited by 7
177 Cardiovascular Risk Factors, Classified in 10 Categories, to be Considered in the Prevention of Cardiovascular Diseases: An Update of the Original 1982 Article Containing 96 Risk Factors
Omura, Y., Lee, A. Y., Beckman, S. L., Simon, R., Lorberboym, M., Duvvi, H., Heller, S. I., & Urich, C. (1996) · Acupuncture & Electro-Therapeutics Research · doi:10.3727/036012996816356942 · Cited by 7
Inflammation und Plaqueinstabilität
Hoffmeister, H. M., Helber, U., & Seipel, L. (1998) · Zeitschrift für Kardiologie · doi:10.1007/s003920050524 · Cited by 7
Helicobacter pylori: opportunistic member of the normal microflora or agent of communicable disease?
Lee, A. (1999) · Springer eBooks · doi:10.1007/978-1-4757-3021-0_6 · Cited by 6
Platelet Characterization in Helicobacter Pylori Patients
Ali, S. A., & Gaufri, N. E. A. M. (2017) · OALib · doi:10.4236/oalib.1103637 · Cited by 6
Association of elevation of anti-helicobacter pylori antibody with myocardial ischemic events in coronary artery disease
Tsai, W., Li, Y., Sheu, B., Tsai, L.-M., Chao, T., Lin, L.-J., & Chen, J.-H. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01439-4 · Cited by 6
Short-term prognostic value of CRP in the patients with acute coronary syndrome
Kim, T. I., Chae, S. C., Yang, D. H., Shin, S. C., Bae, H. S., Kwak, D. H., Hwang, J. H., Cho, Y. G., Jun, J. E., & Park, W. H. (2000) · Korean Circulation Journal · doi:10.4070/kcj.2000.30.11.1387 · Cited by 6
Is there an antigenic mimicry between arteriosclerotic lesions and H. pylori antigens?
Cammarota, G., Figura, N., Cianci, R., Pasceri, V., Fedeli, P., Lenzi, G. C., & Gasbarrini, A. (2000) · Clinical Biochemistry · doi:10.1016/s0009-9120(00)00148-x · Cited by 6
Helicobacter pylori, Chlamydia pneumoniae, and Cytomegalovirus: Chronic Infections and Coronary Heart Disease
Wierzbicki, W. B., & Hagmeyer, K. O. (2000) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.20.1.52.34659 · Cited by 6
Helicobacter pylori infection is not a correlate of plasma fibrinogen in the Australian population
Peach, H. G., Bath, N. E., & FARISH, S. J. (1999) · Clinical & Laboratory Haematology · doi:10.1046/j.1365-2257.1999.00167.x · Cited by 6
Microbial Risk Factors of Cardiovascular and Cerebrovascular Diseases: Potential Therapeutical Options
Abbas, M. A., Güenther, A., Galantucci, S., Fawi, G., Comi, G., Kwan, J. S. K., & Corea, F. (2008) · The Open Neurology Journal · doi:10.2174/1874205x00802010020 · Cited by 6
The association between Chlamydia pneumoniae DNA in arherosclerotic plaque and major risk factors in patients undergoing coronary artery bypass grafting.
Hedayat, D. K., Jebeli, M., Mandegar, M. H., Bagheri, J., Nabavi, S. A., Eghtesadi-Araghi, P., Mohammadzadeh, R., Darehzereshki, A., Chitsaz, S., & Abbasi, A. (2009) · PubMed · Cited by 6
Helicobacter pylori in intensive care: why we should be interested
Robertson, M. S., Clancy, R. L., & Cade, J. F. (2003) · Intensive Care Medicine · doi:10.1007/s00134-003-1838-4 · Cited by 6
Helicobacter pylori and its interaction with risk factors for chronic disease
Jenkins, D. J. A. (1997) · BMJ · doi:10.1136/bmj.315.7121.1481 · Cited by 6
Cholesterol: an important but relatively overemphasized risk factor for ischemic heart disease
Hellstrom, H. R. (2001) · Medical Hypotheses · doi:10.1054/mehy.2001.1418 · Cited by 6
Immune response to a conserved enteroviral epitope of the major capsid VP1 protein is associated with lower risk of cardiovascular disease
Pupina, N., Avarlaid, A., Sadam, H., Pihlak, A., Jaago, M., Tuvikene, J., Rähni, A., Planken, A., Planken, M., Kalso, E. A., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.103835 · Cited by 5
Lipid profile in subjects with Helicobacter pylori infection.
Aarabi, M. H., Alvani, S., & Ehteram, H. (2010) · Iranian journal of pathology · Cited by 5
Helicobacter pylori Infection is a Significant Factor Risk for Hyperhomocysteinemia in the Patients with Coronary Artery Disease
Fallah, S., Hemmat Highy way, I., Moradi, N., Fadaei, R., Reza, A., Azardokht, T., & Seifi, M. (2016) · Brazilian Archives of Biology and Technology · doi:10.1590/1678-4324-2016150509 · Cited by 5
Emerging concepts in disease management: a role for antimicrobial therapy in coronary artery disease
Girard, S. E., & Temesgen, Z. (2001) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2.5.765 · Cited by 5
Chronic Peripheral Arteriopathy Is Associated with Seropositivity toChlamydia pneumoniae
Signorelli, S. S., Stivala, A., Pino, L. D., Salmeri, M., Tempera, G., Toscano, M. A., & Nicoletti, G. (2006) · Journal of Chemotherapy · doi:10.1179/joc.2006.18.1.103 · Cited by 5
Death due to unrecognised myocardial infarction causing left ventricular rupture: can we improve the diagnostic rate?
Baker, G., & Koelmeyer, T. D. (1999) · PubMed · Cited by 5
Manifestaciones extradigestivas de la infección por Helicobacter pylori. ¿Ciencia o ficción?
de Argila, C. M., & Boixeda, D. (2000) · Medicina Clínica · doi:10.1016/s0025-7753(00)71277-2 · Cited by 5
Vaccines: An Ongoing Promise?
Alsahli, M., Farrell, R. J., & Michetti, P. (2001) · Digestive Diseases · doi:10.1159/000050670 · Cited by 5
Occurrence of serum class G immunoglobulins interacting with specific antigens of Helicobacter pylori in patients with unstable coronary artery disease and in symptomless individuals.
Rechciński, T., Grębowska, A., Kurpesa, M., Rudnicka, W., Krzemińska‐Pakuła, M., & Chmiela, M. (2005) · PubMed · Cited by 5
Nanoparticles as Precious Stones in the Crown of Modern Molecular Biology
Kumar, M. R., & Sophia, P. J. (2018) · Springer eBooks · doi:10.1007/978-3-319-61343-7_16 · Cited by 4
Chlamydia pneumoniae and the Cardiovascular System
Diseases, H. O. I. (2003) · Springer eBooks · doi:10.1007/0-306-47926-5_5 · Cited by 4
Histopathology Features ofH. pyloriGastritis Associated With Altered Lipid Profile: An Observational Study from a Tertiary Healthcare Center in North West Romania
Cardos, I. A., Dănilă, C., Ghitea, T. C., Pop, O. L., Paşcalău, A. V., & Cavalu, S. D. (2024) · In Vivo · doi:10.21873/invivo.13584 · Cited by 4
The association of acute aortic dissection with Helicobacter pylori virulence specific serotypes: Distinct diversity of systemic antibodies to CagA and VacA genotypes
Mannacio, V. A., Amicis, V. D., Tommaso, L. D., Stassano, P., Iorio, F., & Vosa, C. (2010) · Surgery · doi:10.1016/j.surg.2010.06.009 · Cited by 4
49. Hyperfibrinogenemia and cardiovascular risk: possible strategies for intervention
Köenig, W. (1996) · Fibrinolysis and Proteolysis · doi:10.1016/s0268-9499(96)80626-6 · Cited by 4
Asociación entre enfermedad cardiovascular y anticuerpos contra Chlamydia pneumoniae
García-Elorriaga, G. D. L. A., Calderón-Abbo, M., & González-Bonilla, C. R. (2002) · Salud Pública de México · doi:10.1590/s0036-36342002000300008 · Cited by 4
Kawasaki Disease and Chlamydia Pneumoniae Infection
Numazaki, K., & Chiba, S. (1996) · Journal of Infection and Chemotherapy · doi:10.1007/bf02355125 · Cited by 4
Chlamydia pneumoniae‐reactive T lymphocytes in abdominal aortic aneurysms: the smoking gun?
Felton, J. M., & Mabey, D. C. W. (1999) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1999.00504.x · Cited by 4
Strong correlation between Helicobacter pylori seropositivity and Chlamydia pneumoniae IgG concentrations.
Danesh, J., Wong, Y.-K., Ward, M. E., Hawtin, P. R., Murphy, M., & Muir, J. (1998) · Journal of Epidemiology & Community Health · doi:10.1136/jech.52.12.821 · Cited by 4
Can the premises of the altered homeostatic theory permit improvement in the prevention of ischemic heart disease?
Hellstrom, H. R. (2002) · Medical Hypotheses · doi:10.1016/s0306-9877(02)00328-6 · Cited by 4
Impact of Helicobacter pylori on prognosis of patients with acute coronary syndrome
Eskandarian, R., Mosavi, S., Babai, M., & Toussy, J. A. (2005) · DOAJ (DOAJ: Directory of Open Access Journals) · doi:10.13140/2.1.2474.9443 · Cited by 3
Traditional and nontraditional lipid parameters in Helicobacter pylori infection
Öztürk, S., Dursun, M. A., Yıldırım, T., Sargın, F., Sargın, Z. G., & Ozan, Z. T. (2024) · Biomarkers in Medicine · doi:10.2217/bmm-2023-0453 · Cited by 4
THROMBOLYSIS WITH INTRAVENOUS STREPTOKINASE DOSE NOT ALTER 72-HOURS MORTALITY IN ACUTE MYOCARDIAL INFARCTION
Rashid, M. A., & Butt, A. K. (2012) · Pakistan Heart Journal · Cited by 3
How to do it: Run a preparation course for postgraduate examinations
Neal, R. D., Maskrey, N., & Williams, M. (1997) · BMJ · doi:10.1136/bmj.314.7092.1468 · Cited by 3
Anticuerpos contra Chlamydophilaen pacientes con infarto agudo del miocardio y riesgo coronario, y su relación con la muerte
García-Elorriaga, G. D. L. A., Sánchez‐Barriga, J. J., Corrales, M. A. R., & González-Bonilla, C. R. (2005) · Salud Pública de México · doi:10.1590/s0036-36342005000300006 · Cited by 3
HOMOCYSTEINE AND MALONDIALDEHYDE AS PREDICTORS OF RESTENOSIS FOLLOWING PERCUTANEOUS CORONARY INTERVENTION
McNair, E. D., Wells, C., Qureshi, M., & Prasad, K. (2006) · ASAIO Journal · doi:10.1097/00002480-200603000-00103 · Cited by 3
Incidence of Chlamydia pneumoniae infection in patients with coronary artery disease subjected to angioplasty or bypass surgery.
Pieniążek, P., Karczewska, E., Stępień, E. Ł., Tracz, W., & Sj, K. (2001) · PubMed · Cited by 3
Extraintestinal Manifestations of H. pylori Infection: Heart Disease
Lim, S. H. (2016) · Springer eBooks · doi:10.1007/978-981-287-706-2_33 · Cited by 3
Distinctive inhibition of alkaline phosphatase isozymes by thiazol‐2‐ylidene‐benzamide derivatives: Functional insights into their anticancer role
Ejaz, S. A., Saeed, A., Shah, S. J. A., Hameed, A., Lecka, J., Sévigny, J., & Iqbal, J. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26692 · Cited by 3
Helicobacter pylori and Gastroduodenal Disorders
Kuipers, E. J., & Blaser, M. J. (2014) · ASM Press eBooks · doi:10.1128/9781555816940.ch13 · Cited by 3
Prevention of Coronary Heart Disease through Treatment of Infection with Chlamydia Pneumoniae? Estimation of Possible Effectiveness and Costs
Sanderson, C. F. B., & Kubin, M. (2001) · Health Care Management Science · doi:10.1023/a:1011838211092 · Cited by 3
The Association of Chlamydia pneumoniae and Atherogenesis
Dunne, M. W. (2014) · ASM Press eBooks · doi:10.1128/9781555816957.ch5 · Cited by 3
Chlamydia pneumoniae y enfermedad cerebrovascular
Palomino, J. P. L., Fernández, J. G., Espada, C. L., Ros-Die, E., Moreno-Escobar, J., Perez, T. A., Rodríguez-Fernández, M., & Maroto-Vela, M. A. C. (2001) · Angiología · doi:10.1016/s0003-3170(01)74680-9 · Cited by 3
Chlamydia and coronary heart disease
Yarnell, J., & Evans, A. (1996) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a014927 · Cited by 3
Commentary: The Incidence of Infectious Diseases and Changes in the Mortality of Atherosclerosis-Related Complications in the Czech Population over the Past Two Decades
Dvorakova, A., & Poledne, R. (2004) · European Journal of Epidemiology · doi:10.1023/b:ejep.0000036769.77566.06 · Cited by 3
Infección, Chlamydia y arteriosclerosis
Núñez-Cortés, J. M. (2003) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/s0214-9168(03)78893-7 · Cited by 3
Editorial Comment—Is Heme Oxygenase-1 a Causal Player for Plaque Stability?
Espinola–Klein, C., Blankenberg, S., & Münzel, T. F. (2005) · Stroke · doi:10.1161/str.36.9.1901 · Cited by 3
Evaluation of the role of Chlamydia pneumoniae in the pathogenesis of atherosclerosis - a review
Scheller, B., Hennen, B., Markwirth, T., & Schieffer, H. J. (2000) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 3
The role of DNA supercoiling in the coordinated regulation of gene expression in Helicobacter pylori
Ye, F. (2004) · Online Publication Service of Würzburg University (Würzburg University) · Cited by 3
Antibiotics for secondary prevention of coronary heart disease
Monk-Hansen, T., Prescott, E., Als-Nielsen, B. E. T., Hróbjartsson, A., Wetterslev, J., & Gluud, C. N. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003610 · Cited by 3
EVALUATION ACTIVITIES OF CHITOSAN ASCORBATE AGAINST RODS OF HELICOBACTER PYLORI ISOLATED FROM GINGIVAL POCKETS AND ATHEROSCLEROTIC PLAQUES
Kędzia, A., Kochańska, B., Gębska, A., Wierzbowska, M., & Kufel, A. (2016) · Progress on Chemistry and application of Chitin and its Derivatives · doi:10.15259/pcacd.21.10 · Cited by 2
DYSLIPIDEMIA;
Karim, I., Zardari, A. K., Shaikh, M. K., Baloch, Z. Q., & Shah, S. Z. A. (2018) · The Professional Medical Journal · doi:10.29309/tpmj/2014.21.05.2529 · Cited by 2
High Frequency ofChlamydophila pneumoniaeInfection: Patients with Peripheral Arterial Disease and Those with Risk Factors for Cardiovascular Diseases Compared to Normal Subjects
Signorelli, S. S., Stivala, A., Bonaccorso, C. M., Anzaldi, M., Fiore, V., Simili, M., Neri, S., Garozzo, A., Tempera, G., & Nicoletti, G. (2010) · Journal of Chemotherapy · doi:10.1179/joc.2010.22.6.392 · Cited by 2
A Botanical Protocol for Helicobacter pylori Infection
Heron, S., & Yarnell, E. L. (2000) · Alternative and Complementary Therapies · doi:10.1089/act.2000.6.60 · Cited by 2
Chronic Chlamydia pneumoniae Infection as a Risk Factor for Acute Myocardial Infarction in Korea
Lee, E. M., Oh, D. J., Hwang, G., Ahn, J. C., Song, W. H., Lim, D., Park, C. G., Kim, Y., Seo, H. S., Shim, W. J., et al. (2000) · Korean Circulation Journal · doi:10.4070/kcj.2000.30.4.407 · Cited by 2
High prevalence of chlamydia pneumoniae seropositivity in mexican patients with ischemic heart disease
Meza–Junco, J., Montaño‐Loza, A. J., Castillo‐Martínez, L., Orea‐Tejeda, A., Remes-Troche, J. M., Villalobos-Zapata, I., Ponce‐de‐León, A., & Calva, J. J. (2004) · Archives of Medical Research · doi:10.1016/j.arcmed.2004.03.005 · Cited by 2
Chlamydia trachomatis: Aspectos microbiológicos, clínicos y epidemiológicos.
Matta, S., Arango, Á. I., & Visbal, J. (2001) · Revista Mvz Córdoba · doi:10.21897/rmvz.528 · Cited by 2
Helicobacter spp. — Food- or Waterborne Pathogens?
Doyle, M. E. (2012) · Cited by 2
Helicobacter pyloriInfection and Extra-gastroduodenal Diseases
Kim, B. (2015) · The Korean Journal of Helicobacter and Upper Gastrointestinal Research · doi:10.7704/kjhugr.2015.15.4.225 · Cited by 2
Hyperfibrinogenemia and cardiovascular risk: possible strategies for intervention
Köenig, W., Hoffmeister, A., & Hombach, V. (1997) · Fibrinolysis and Proteolysis · doi:10.1016/s0268-9499(97)80021-5 · Cited by 2
Prevalence of Helicobacter pylori in Relation to Promotive Factors among Human Urban Population of Bahawalpur District, Pakistan
Zaman, R.-U. (2006) · Pakistan Journal of Biological Sciences · doi:10.3923/pjbs.2006.2636.2641 · Cited by 2

Authors: Patel, P., Mendall, M. A., Carrington, D., Strachan, D. P., Leatham, E., Molineaux, N., Levy, J., Blakeston, C., Seymour, C. A., Camm, A. J., & Northfield, T. C.
Affiliations: St George's, University of London (GB)
ORCID: Patel, P
Strachan, D P
Camm, A J
Venue: BMJ
Publisher: BMJ
Published: 1995-09-16
Volume: 311
Issue: 7007
Pages: 711-714
ISSN: 0007-1447 (ISSN-L)
0959-8138
1468-5833
DOI: 10.1136/bmj.311.7007.711
PMC: PMC2550716
OpenAlex: W1988289155
Cited by: 592
References: 32
Citations by year: 2026: 2 · 2025: 1 · 2024: 5 · 2023: 3 · 2022: 7 · 2021: 4 · 2020: 7 · 2019: 6 · 2018: 14 · 2017: 5 · 2016: 4 · 2015: 11 · 2014: 12 · 2013: 6 · 2012: 12
FWCI: 54.25
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.bmj.com/company/legal-information/terms-conditions/legal-information/tdm-licencepolicy (tdm)
Locations: BMJ (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
HighWire Press Open Archive (submittedVersion)
Topics: Health Sciences › Medicine › Gastroenterology › Helicobacter pylori-related gastroenterology studies
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
Keywords: Helicobacter pylori, Chlamydia pneumoniae, coronary artery disease, cardiovascular risk factors, seropositivity, chronic infection, fibrinogen, malondialdehyde, white blood cell count, myocardial infarction, low-grade inflammation, men
MeSH terms: Aged, C-Reactive Protein, Chlamydia Infections, Coronary Disease, Cross-Sectional Studies, Electrocardiography, Fibrinogen, Humans, Leukocyte Count, London, Male, Middle Aged, Risk Factors, Helicobacter pylori, Helicobacter Infections, Chlamydophila pneumoniae

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Citations

Cites

Cited by

Related

Metadata

Record

About these checks